Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 530 | 20.32 |
09:41 ET | 300 | 20.34 |
09:59 ET | 163 | 20.5611 |
10:03 ET | 582 | 20.3928 |
10:08 ET | 100 | 20.245 |
10:10 ET | 100 | 20.1 |
10:12 ET | 109 | 20.205 |
10:19 ET | 100 | 20.245 |
10:21 ET | 400 | 20.16 |
10:26 ET | 100 | 20.03 |
10:30 ET | 517 | 20 |
10:33 ET | 225 | 20.054 |
10:35 ET | 350 | 20 |
10:37 ET | 100 | 20.01 |
10:39 ET | 625 | 19.9115 |
10:42 ET | 700 | 20.2 |
10:46 ET | 252 | 20.2 |
10:50 ET | 300 | 20.35 |
10:51 ET | 128 | 20.57 |
10:53 ET | 162 | 20.485 |
10:55 ET | 700 | 20.7 |
10:57 ET | 1508 | 20.71 |
11:00 ET | 300 | 20.9 |
11:22 ET | 101 | 20.58 |
11:26 ET | 225 | 20.5524 |
11:31 ET | 100 | 20.615 |
11:36 ET | 472 | 20.6836 |
11:42 ET | 200 | 20.64 |
11:49 ET | 271 | 20.62 |
11:51 ET | 600 | 20.69 |
11:54 ET | 600 | 20.7954 |
11:58 ET | 132 | 20.84 |
12:00 ET | 300 | 20.702 |
12:02 ET | 200 | 20.74 |
12:03 ET | 200 | 20.84 |
12:09 ET | 449 | 20.782 |
12:12 ET | 100 | 20.87 |
12:16 ET | 100 | 20.88 |
12:18 ET | 346 | 20.785 |
12:21 ET | 200 | 20.76 |
12:25 ET | 100 | 20.725 |
12:27 ET | 100 | 20.745 |
12:32 ET | 267 | 20.7 |
12:34 ET | 6650 | 20.37 |
01:14 ET | 14449 | 19.72 |
01:17 ET | 100 | 19.9 |
01:21 ET | 200 | 19.925 |
01:26 ET | 5525 | 19.78 |
01:32 ET | 100 | 19.7 |
01:35 ET | 250 | 19.7074 |
01:37 ET | 100 | 19.765 |
01:44 ET | 964 | 19.69 |
01:46 ET | 100 | 19.87 |
02:00 ET | 200 | 19.84 |
02:02 ET | 1000 | 20.01 |
02:04 ET | 2250 | 20.49 |
02:06 ET | 2238 | 20.411 |
02:08 ET | 4900 | 20.41 |
02:09 ET | 9173 | 20.415 |
02:11 ET | 1000 | 20.325 |
02:13 ET | 500 | 20.04 |
02:15 ET | 100 | 20.3801 |
02:18 ET | 318 | 20.16 |
02:20 ET | 500 | 20.56 |
02:22 ET | 100 | 20.5 |
02:24 ET | 100 | 20.56 |
02:26 ET | 100 | 20.57 |
02:27 ET | 1268 | 20.3796 |
02:29 ET | 496 | 20.58 |
02:31 ET | 100 | 20.68 |
02:33 ET | 100 | 20.68 |
02:36 ET | 994 | 20.91 |
02:38 ET | 100 | 20.85 |
02:40 ET | 963 | 20.8859 |
02:42 ET | 400 | 20.88 |
02:44 ET | 263 | 20.87 |
02:45 ET | 1300 | 20.72 |
02:47 ET | 200 | 20.62 |
02:49 ET | 300 | 20.39 |
02:51 ET | 749 | 20.38 |
02:54 ET | 1000 | 20.62 |
02:56 ET | 651 | 20.75 |
02:58 ET | 625 | 20.7557 |
03:00 ET | 200 | 20.66 |
03:02 ET | 400 | 20.55 |
03:03 ET | 100 | 20.51 |
03:05 ET | 300 | 20.58 |
03:07 ET | 200 | 20.25 |
03:09 ET | 1322 | 20.25 |
03:12 ET | 875 | 20.24 |
03:14 ET | 600 | 20.36 |
03:16 ET | 900 | 20.345 |
03:18 ET | 700 | 20.37 |
03:20 ET | 300 | 20.41 |
03:21 ET | 100 | 20.21 |
03:23 ET | 3624 | 20.03 |
03:25 ET | 428 | 19.986 |
03:27 ET | 10811 | 19.74 |
03:30 ET | 350 | 19.7 |
03:34 ET | 200 | 19.8999 |
03:36 ET | 182 | 19.7 |
03:38 ET | 23687 | 19.07 |
03:39 ET | 5999 | 18.98 |
03:43 ET | 1140 | 18.97 |
03:45 ET | 1988 | 18.93 |
03:48 ET | 300 | 18.845 |
03:50 ET | 200 | 18.92 |
03:52 ET | 204 | 18.905 |
03:54 ET | 481 | 18.95 |
03:56 ET | 4311 | 19.125 |
03:57 ET | 3481 | 19.06 |
03:59 ET | 19369 | 18.98 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 1.2B | -24.0x | --- |
Nano-X Imaging Ltd | 366.2M | -6.3x | --- |
Atlantic International Corp | 292.4M | -0.7x | --- |
Simulations Plus Inc | 629.2M | 66.3x | +3.18% |
IRadimed Corp | 613.9M | 33.1x | +21.02% |
Clearpoint Neuro Inc | 321.8M | -16.5x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.75 |
EPS | $-0.79 |
Book Value | $0.80 |
P/E Ratio | -24.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.